Treated in only 3 VISITS!   214.379.2700
  • Targeted Prostate Cancer Treatment Becoming the Norm

    As one of the leading cancer killers of men in the United States, prostate cancer has long been treated aggressively. While beneficial for those who see their survivability rates rise, aggressive treatments are not always needed and may, indeed, lead to unnecessary side effect risks in some cases. After years of a push-and-pull on the best treatment protocols, more doctors...

  • Better Prostate Cancer Screenings Needed

    Prostate cancer screening is effective, but it isn’t without its share of problems. The standard Prostate-Specific Antigen blood test, for example, can help doctors see if there might be a cause to explore the possibilities further. Elevated PSA levels may indicate the presence of cancer, after all. These tests sometimes produce false positives, which is why biopsies are often...

  • Active Surveillance Becoming a Popular Prostate Cancer Option

    A diagnosis of cancer means the time for immediate, often aggressive, action has arrived. While that might be true with many forms of the disease, sometimes waiting and watching is the best approach to take with prostate cancer. While this particular fact has long been known, men for quite some time were still opting for more aggressive treatments. The...

  • Could Balding Signal a Higher Prostate Cancer Risk?

    As medical science strives to gain a better understanding on what makes one man more likely to develop prostate cancer than another, new research is shedding light on a possible link between balding and this disease. The balding pattern, however, has to be pretty particular for risk levels to rise, a new study indicates. The latest findings come from a...

  • Prostate Cancer Market Anticipated to Grow Through 2023

    Prostate cancer is the second leading cause of cancer in men worldwide. It comes in second only to skin cancer in its number of global cases, representing some 15 percent of all cancers diagnosed in men. Considering this, it’s little surprise that researchers say the global market associated with prostate cancer will grow by leaps and bounds through 2023. In...

  • Western Diets May Kill Prostate Cancer Survivors

    With more than 220,000 new cases of prostate cancer diagnosed annually in the United States, this disease is a concern for all males as they age. This disease is considered the second leading cause of cancer deaths in American men, but it can be easy to eradicate when it is caught early. The problem, however, is that sometimes the...

  • Prostate Cancer: Foods That Help Fight It

    With prostate cancer the second leading cause of cancer-related deaths in American men getting an edge against the disease is a priority for many. Men who want to increase their chances of avoiding this disease will find certain foods can help. While a good diet alone isn’t a guarantee that prostate cancer won’t be a problem for some men, an...

  • New Hope for Advanced Prostate Cancer Found in Breast Cancer Drug

    A new cancer drug originally developed to help treat women with rare forms of ovarian and breast cancer may also provide a ray of hope for men suffering from a normally deadly form of advanced prostate cancer. A small clinical study involving the use of this drug was recently staged with results that were quite promising. The drug, researchers fund,...

  • Is Baldness a Prostate Cancer Risk?

    There are a number of risk factors for prostate cancer that men are urged to be mindful of. A new potential marker might be a little easier than others to detect. A study published in the Journal of Clinical Oncology indicates there may be a link between prostate cancer and an early onset of typical male pattern baldness. Prostate cancer...

  • Cholesterol Drugs May Slow Progression of Prostate Cancer

    A common drug used to lower cholesterol levels may have a positive impact on the battle against prostate cancer. Researchers at the Dana-Farber Cancer Institute in Boston have found that men who were taking statins while undergoing hormone therapy noticed marked slowing of the disease’s progression versus men who were not taking statins. The study involved 926 men undergoing hormone...